This trial is active, not recruiting.

Condition healthy
Treatment slow sodium tablets
Sponsor Charite University, Berlin, Germany
Start date July 2015
End date June 2016
Trial size 14 participants
Trial identifier NCT02509962, Tissue Salt 3


To study the effects of an increased salt intake on metabolic, cardiovascular and immunoregulatory functions in healthy men.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Intervention model single group assignment
Masking open label
Primary purpose basic science
Increased dietary salt intake
slow sodium tablets
6 g sodium chloride per day over 14 days

Primary Outcomes

Postprandial energy expenditure within 4h after a meal, measured by indirect calorimetry (respiratory chamber)
time frame: Change to baseline at day 14

Eligibility Criteria

Male participants from 20 years up to 50 years old.

Inclusion Criteria: - body mass index 18.5 - 29.9 kg/m2 Exclusion Criteria: - clinically relevant heart, lung, liver, and kidney diseases

Additional Information

Official title Effects of Increased Salt Intake on Metabolic, Cardiovascular and Immunoregulatory Functions in Healthy Men
Principal investigator Michael Boschmann, Dr.
Trial information was received from ClinicalTrials.gov and was last updated in January 2017.
Information provided to ClinicalTrials.gov by Charite University, Berlin, Germany.